BIIB price target
Biogen Inc. · end-of-day data as of Oct 16, 2026
Biogen Inc.
$232.65+15.1%
Buy · 37 analystsPT $238.98 +2.7%
The average price target of the 22 analyst firms that published one in the last 12 months is $238.98 for BIIB, 2.7% above the last close of $232.65 on Oct 16, 2026. Targets range from $178.90 to $302.56, with a median of $246.56. Rating consensus: Buy.
Summary
- Target upside+2.7%
- ConsensusBuy
Analyst price targets
Low$178.90
Average$238.98
Median$246.56
High$302.56
Upside+2.7%
22 firms with a target in the last 12 months · last close $232.65 · as of Oct 16, 2026
Robert W. Baird$2542025-10-31
Morgan Stanley$1562025-12-12
HSBC$1442025-12-10
Piper Sandler$1642025-11-21
Bernstein$1542025-11-03
Tudor Pickering$1552025-11-03
Barclays$1852026-02-19
Mizuho Securities$2392026-02-11
Wedbush$1832026-02-10
Canaccord Genuity$2222026-02-09
H.C. Wainwright$2202026-02-09
Piper Sandler$1712026-02-09
+11 more
Guggenheim$2372026-02-09
Oppenheimer$2302026-01-30
Goldman Sachs$2242026-01-08
Morgan Stanley$2222026-06-18
Mizuho Securities$2192026-06-15
Needham$2512026-06-08
RBC Capital$2322026-05-27
Piper Sandler$2272026-05-15
Morgan Stanley$2072026-04-30
+4 more
Guggenheim$2532026-04-30
Wells Fargo$2582026-04-20
HSBC$1532026-07-06
Stifel Nicolaus$2432026-09-10
Piper Sandler$2472026-09-03
RBC Capital$2632026-08-25
Canaccord Genuity$2462026-07-30
H.C. Wainwright$2542026-07-30
Morgan Stanley$2332026-07-30
+6 more
Wolfe Research$3032026-08-13
Oppenheimer$3002026-07-29
Guggenheim$2802026-07-21
HSBC$1792026-09-10
BMO Capital$2172026-10-12
UBS$2732026-10-09
RBC Capital$2542026-10-08
— actual price● bullish target● bearish targethover a dot to see the analysts behind it · wheel or drag to move through time · drag the price axis on the right to stretch it · double-click resets
Strong buy 4 · Buy 20 · Hold 12 · Sell 1 · Strong sell 0